Loading clinical trials...
Loading clinical trials...
An Open Label Study of STR04 in Participants With Amyotrophic Lateral Sclerosis
Conditions
Interventions
STR04
Locations
1
United States
National Neuromuscular Research Institute
Austin, Texas, United States
Start Date
August 12, 2025
Primary Completion Date
December 16, 2025
Completion Date
December 16, 2025
Last Updated
December 18, 2025
NCT07322003
NCT07414212
NCT05104710
NCT03233646
NCT07357428
NCT04715399
Lead Sponsor
New England Cell Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions